Trial Profile
Dose response, pharmacodynamic and pharmacokinetic study of P-3074, a new finasteride 0.25% topical solution, after 7-day multiple dose administration in male volunteers with androgenetic alopecia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jun 2014
Price :
$35
*
At a glance
- Drugs Finasteride (Primary)
- Indications Alopecia
- Focus Pharmacokinetics
- Sponsors Polichem
- 11 Jun 2014 New trial record